INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 17, 2018 |
Director, President and Chief Scientific
|
Director, President and Chief Scientific | Form 4 | Other acquisition or disposition | -- | -- | 400,000 |
| Dec 14, 2018 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Other acquisition or disposition | -- | -- | 5,728 |
| Dec 13, 2018 |
Director, President and Chief Scientific
|
Director, President and Chief Scientific | Form 4 | Bona fide gift | 118,993 | -- | -- |
| Dec 13, 2018 |
Director, President and Chief Scientific
|
Director, President and Chief Scientific | Form 4 | Bona fide gift | 118,993 | -- | 602,594 |
| Dec 13, 2018 |
Director, President and Chief Scientific
|
Director, President and Chief Scientific | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 150,000 | -- | 94,048 |
| Dec 13, 2018 |
Director, President and Chief Scientific
|
Director, President and Chief Scientific | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 94,048 | -- | -- |
| Dec 12, 2018 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 129,013 | -- | 129,013 |
| Nov 16, 2018 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 1,176 | -- | 483,601 |
| Nov 01, 2018 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 24,643 | -- | -- |
| Aug 22, 2018 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 3,211 | -- | 484,777 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.